Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
Conditions
Interventions
Ruxolitinib cream
Vehicle cream
Locations
26
United States
UNIVERSITY OF ALABAMA AT BIRMINGHAM (UAB), 1802 6th Ave S
Birmingham, Alabama, United States
BURKE PHARMACEUTICAL RESEARCH LLC, 3633 Central Ave
Hot Springs, Arkansas, United States
NORTHWEST AR CLINICAL TRIALS CENTER, PLLC/HULL DERMATOLOGY, PA, 500 S 52nd Street
Rogers, Arkansas, United States
THE VITILIGO & PIGMENTATION INSTITUE OF SOUTHERN CALIFORNIA, 5670 Wilshire Boulevard
Los Angeles, California, United States
DERMATOLOGY RESEARCH ASSOCIATES- LOS ANGELES, 8930 S Sepulveda Blvd
Los Angeles, California, United States
DERMATOLOGY SPECIALISTS, 3629 Vista Way
Oceanside, California, United States
Start Date
June 7, 2017
Primary Completion Date
September 12, 2018
Completion Date
September 8, 2021
Last Updated
November 17, 2022
NCT07431177
NCT07352293
NCT07437560
NCT07398807
NCT07357870
NCT07267273
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions